Anzeige
Mehr »
Login
Montag, 29.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Basin Uranium: Es geht los! Der Uran-Superzyklus ist gestartet!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DTYN | ISIN: US98423J1016 | Ticker-Symbol:
NASDAQ
26.04.24
22:00 Uhr
9,920 US-Dollar
+0,080
+0,81 %
Branche
Software
Aktienmarkt
S&P SmallCap 600
1-Jahres-Chart
XPERI INC Chart 1 Jahr
5-Tage-Chart
XPERI INC 5-Tage-Chart

Aktuelle News zur XPERI Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
17.04.Rubric Capital Management Files Definitive Proxy Statement For Xperi Inc. 2024 Annual Meeting; Highlights Poor Operational Performance, Egregious Executive Compensation And Reckless Capital Allocation Under Incumbent Board1
08.04.Xperi Inc. - 8-K, Current Report1
11.03.Xperi holder Rubric files preliminary proxy to nominate two directors for board2
01.03.Xperi Inc. - 10-K, Annual Report1
29.02.Xperi Inc reports results for the quarter ended in December - Earnings Summary2
28.02.Xperi Non-GAAP EPS of $0.11 beats by $0.06, revenue of $137.23M misses by $3.49M2
28.02.Xperi Inc. - 8-K, Current Report1
28.02.Xperi Inc. Announces Fourth Quarter and Full Year 2023 Results132SAN JOSE, Calif.--(BUSINESS WIRE)--Xperi Inc. (NYSE: XPER) (the "Company" or "Xperi"), an entertainment technology company that invents, develops, and delivers technologies that enable extraordinary...
► Artikel lesen
27.02.TiVo Broadband signs up first operator customers1
26.02.Xperi Signs Up Four U.S. Telcos for TiVo Broadband-
26.02.TiVo Broadband signs four new operators1
26.02.TiVo Broadband expands with four new operators1
06.02.AVEO Pharmaceuticals, Inc.: AVEO Oncology Announces Publication of Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib: Analysis of the Phase III TIVO-3 Trial in The Oncologist235BOSTON, Feb. 06, 2024 (GLOBE NEWSWIRE) -- AVEO Oncology, an LG Chem company ("AVEO"), today announced The Oncologist has published a post-hoc analysis of long-term progression free survival, overall...
► Artikel lesen
01.02.Xperi Inc. - 8-K, Current Report-
30.01.TiVo: Execs urges personalisation is key to driving user engagement1
27.01.Activist Rubric nominates two directors at Xperi. Here's how the firm may help enhance shareholder value2
24.01.Xperi Inc: Xperi Launches First UK In-Car Entertainment Report, Consumers Call for a Personalised Entertainment Dash262Nearly half (42%) of UK adults insist in-car entertainment systems need to go beyond being a mirror of their smartphone High-quality video capabilities are a deciding factor in vehicle...
► Artikel lesen
23.01.Xperi gains amid report holder Rubric pushing for cost cuts, AI review1
23.01.Xperi Holder Rubric Pushes for Cost Cuts, AI Unit Review1
12.01.Xperi Inc. - 8-K, Current Report1
Seite:  Weiter >>
37 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1